Company Profile

Cash Flow

AKUMS DRUGS & PHARMACEUTICALS LTD.

NSE : AKUMSBSE : 544222ISIN CODE : INE09XN01023Industry : Pharmaceuticals & DrugsHouse : Private

BSE514.85-2.55 (-0.49 %)

PREV CLOSE ( ) 517.40

OPEN PRICE ( ) 521.20

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 5995

TODAY'S LOW / HIGH ( )511.30 524.75

52 WK LOW / HIGH ( )407.4 1174.85

NSE513.90-5.35 (-1.03 %)

PREV CLOSE( ) 519.25

OPEN PRICE ( ) 520.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 513.90 (34)

VOLUME 263863

TODAY'S LOW / HIGH( ) 510.70 524.85

52 WK LOW / HIGH ( )405 1175.9

Particulars

Mar 2025

Mar 2024

Mar 2023

Mar 2022

Mar 2021

Profit Before Tax

3452.53

-452.78

1502.97

-1931.97

1722.61

Adjustment

1677.09

5560.90

1577.31

6314.24

1440.22

Changes In working Capital

334.69

498.67

-343.34

-3515.55

-1368.43

Cash Flow after changes in Working Capital

5464.31

5606.79

2736.94

866.72

1794.40

Cash Flow from Operating Activities

4651.96

4982.59

1766.31

318.54

1338.87

Cash Flow from Investing Activities

-5478.43

-3304.15

-3047.02

-2348.22

-1093.85

Cash Flow from Financing Activities

727.88

-1080.21

1245.40

2360.40

-947.35

Net Cash Inflow / Outflow

-98.59

598.23

-35.31

330.72

-702.33

Opening Cash & Cash Equivalents

1110.50

516.08

551.39

220.67

917.89

Cash & Cash Equivalent on Amalgamation / Take over / Merger

-3.81

5.11

Cash & Cash Equivalent of Subsidiaries under liquidations

Translation adjustment on reserves / op cash balalces frgn subsidiaries

Effect of Foreign Exchange Fluctuations

Closing Cash & Cash Equivalent

1011.91

1110.50

516.08

551.39

220.67